Clinicians in participating countries can contact us to discuss enrolling their eligible patients in the trial
Participating countries: UK, Belgium, Spain, Russia, South Africa, Brazil, Australia, Germany and India.
Email us to get involved.
A critical question, a unique opportunity
There is no hard data supporting the use of these anticoagulants in a community setting for COVID-19 patients. ETHIC could provide this data. Learn more about why ETHIC matters.